Sam Konduros

  • Sam Patrick posted an article
    SCBIO believes growing the life sciences sector will significantly transform the state’s economy. see more

    Compliments of the Community Journal...

    It was all smiles on Sept. 30 as BMW marked the 25th anniversary of the first vehicle to roll off its Spartanburg assembly line, a singular moment that dramatically transformed the economic face of South Carolina.

    A quarter-century after opening, the German manufacturer’s North American facility employs more than 11,000 workers who build 1,500 vehicles daily, a pace requiring the services of more than 40 main suppliers across the state.

    The average wage among all S.C. jobs supported by the automotive industry stood at $64,120 in 2017 compared to $40,293 across all employment categories, say findings commissioned by the South Carolina Biotechnology Industry Organization (SCBIO).

    Now three years old, SCBIO is spearheading an aggressive initiative to make South Carolina the preferred location for new or expanding companies in another highly promising industry: life sciences.  Read the entire story by clicking here.

  • Sam Patrick posted an article
    Industry leaders in Greenville salute AVX, Pastides, Youkey for advancing SC life sciences see more

    450 industry leaders in Greenville salute honorees for advancing South Carolina’s life sciences, discuss avenues to “Ignite the Future” of fast-growing industry

    NOVEMBER 4, 2019 – To resounding applause from a record gathering from 11 countries, 32 states and virtually every county in South Carolina, life sciences leaders at SCBIO 2019 in Greenville saluted three leaders – two individuals and one organization – for profound positive impact and exceptional contributions to the advancement of South Carolina’s $11.4 billion life sciences industry.

    Retired University of South Carolina President Dr. Harris Pastides was presented with the South Carolina Life Sciences Hall of Fame Award for his personal championing of the life sciences industry, which today has an $11.4 billion annual economic impact in the Palmetto State, with more than 670 firms directly involved and over 43,000 professionals employed in the research, development and commercialization of innovative healthcare, medical device, industrial, environmental and agricultural biotechnology products.  The University of South Carolina is a Mission Partner of SCBIO and has been highly instrumental in helping the rapid growth of life sciences in the Palmetto State.

    Recently retired as USC’s 28th president, Dr. Pastides has led the school’s eight institutions in 19 locations to high achievement and growth.  He took USC’s helm in 2008, launching an unprecedented construction expansion of more than $1 billion in projects, and growing student enrollment by 25 percent to more than 51,000 students. Under his tenure, the USC Honors College has risen to the No. 1 public honors college in the nation and celebrated increased research funding and top rankings in undergraduate and graduate international business, public health, engineering and nursing.  In 2016, Dr. Pastides became one of seven Fulbright alumni to receive the inaugural Global Changemaker Award in recognition of his ongoing commitment to transform society and humanity through his work. Before joining USC as dean of the Arnold School of Public Health, Dr. Pastides was chairman of the Department of Biostatistics and Epidemiology at the University of Massachusetts Amherst. He received two masters’ degrees and a Ph.D. in Epidemiology from Yale University.  The award was presented by Hank Jibaja, CIO of sponsoring organization Nephron Pharmaceuticals.

    Presented with the South Carolina Life Sciences Pinnacle Award for Organizational Contribution to the industry was AVX Corporation of Fountain Inn, represented by Robert J. Fairey, Vice President of the Medical Division of AVX Corporation.  A Mission Partner of SCBIO, AVX components are used in most implantable life support devices globally, and the company is expanding its passive component and interconnect product portfolio to serve other segments of the medical electronics industry. With over 20 years’ experience supplying electronic components to the medical device industry, AVX offers leading technology, reliability and a deep understanding of the requirements set forth from the medical industry. AVX’s quality systems lead the industry and support customer-specific change control, documentation, specifications and testing procedures.

    A South Carolina native and Clemson University graduate with B.S. and M.S. degrees in Management, Mr. Fairey serves as Vice President, Medical Division for AVX Corporation in Fountain Inn, South Carolina. For over 25 years, he has been involved in developing, manufacturing and marketing capacitors and other AVX components for pacemakers, implantable defibrillators and other lifesaving and life-enhancing products.

    Presented with the South Carolina Life Sciences Pinnacle Award for Individual Contribution to the industry was Dr. Jerry Youkey, recently retired EVP and Chief Academic Officer of Prisma Health and Founding Dean of the USC School of Medicine – Greenville.  Dr. Youkey joined Greenville Health System (now Prisma) in 1998 and was responsible for expansion of the health system’s research and education activities, creation of its 1200 physician group practice, progressive integration of hospital-physician patient care, and for the growing USC health sciences presence in the Upstate. Dr. Youkey previously served as chief of the department of surgery at Geisinger Medical Center in Danville, Pennsylvania and in the United States Army Medical Corps where he attained the rank of lieutenant colonel.  Certified by the American Board of Surgery in general vascular surgery, he is a member of numerous professional societies and widely published. On September 30, 2019 he was designated Founding Dean Emeritus by the University of South Carolina. In recognition of his transformative health care leadership, Governor Henry McMaster conferred upon Dr. Youkey the Order of the Palmetto for his contributions to the state of South Carolina.

    The three honorees joined such noted speakers as Johnson & Johnson Innovation leader Michal Preminger, Medtronic VP of Value-Based Partnerships Christian Howell, South Carolina Lt. Governor Pamela Evette, President Jim Clements of Clemson University and more than 50 additional national speakers at SCBIO 2019 – the annual conference which gathers thought leaders and executives from life sciences organizations across the nation annually.

    The record 450 attendees who filled Hyatt Regency Greenville included scores of top industry chief executives, leaders in government and higher education, biotechnology and pharma executives, clinicians and researchers, and industry supporters from across America including IQVIA Institute of Human Data Science’s Murray Aitken, EY’s NextWave Wellness and life sciences experts Kim Ramko and Kenny O’Neill, Thomas Hardaway of PhRMA, Prisma Health’s President & CEO Mark O’Halla, and numerous others.

    SCBIO is South Carolina’s investor-driven economic development organization exclusively focused on building, advancing, and growing the life sciences industry in the state. 

    “The life sciences industry is a significant driver of South Carolina’s growing knowledge economy, and these honorees and this conference are testament to the industry’s growing impact, reach and rapidly rising economic significance in our state and region,” noted SCBIO President and CEO Sam Konduros. “We’re pleased to honor them for their many contributions and salute them for the advances they have facilitated for this industry.”

    As the official state affiliate of BIO, PhRMA and AdvaMed, SCBIO members include hundreds of academic institutions, biotech companies, medtech companies, entrepreneurial organizations, service providers, thought leaders, economic development organizations and related groups whose members are leading the research and development of innovative healthcare, agricultural, industrial and environmental products that transform how we heal, fuel and feed the world.

    For additional information on SCBIO, visit www.SCBIO.org.

     

    About AVX

    AVX Corporation is a leading international manufacturer and supplier of advanced electronic components, interconnect, sensing, control, and antenna solutions with 29 manufacturing facilities in 16 countries around the world. AVX offers a broad range of devices including capacitors, resistors, filters, couplers, sensors, controls, circuit protection devices, connectors, and antennas. The company is publicly traded on the New York Stock Exchange (NYSE:AVX).

  • Sam Patrick posted an article
    Biopharma research is an important source of jobs, tax revenue and research spending in SC see more

    New findings show biopharma research companies a source of jobs, tax revenue and research spending in state

     

    GREENVILLE, S.C., October 4, 2018 – This week, the Pharmaceutical Research and Manufacturers of America (PhRMA) released a new report that finds there are more than 572 active clinical trials in the South Carolina, and the life science industry supports 29,500 high-quality jobs and contributes $7.9 billion to South Carolina’s economy. These clinical trials can be responsible for more than half of the $2.6 billion average cost of developing one new medicine. They are investigating some of the biggest health care challenges South Carolinians face, including arthritis, cancer, diabetes, cardiovascular disease, and Alzheimer’s disease.

    The report, titled “Research in Your Backyard: Developing Cures, Creating Jobs, Pharmaceutical Clinical Trials in South Carolina,” was released at a press event held at the Westin Poinsett today, which featured a panel discussion including researchers and executives from the Greenville Health System, KIYATEC, the Hollings Cancer Center at MUSC, and the Greenwood Genetic Center, moderated by SCBIO President and CEO, Sam Konduros.

    “Clinical trials offer patients novel medical treatments right here in the Palmetto State, while also allowing biopharma research organizations to innovate and grow,” said Konduros. “Across South Carolina, the life sciences and healthcare industries have had a profound impact on our economy and citizens, that continues to rapidly increase.”

    Clinical trials are a vital component of bringing new life-saving drugs and treatments to market. On average, it takes approximately a decade for new medicines to go through the rigorous Food and Drug Administration (FDA) approval process. Only 12 percent of drugs successfully make it through clinical trials. Since 2004, biopharmaceutical research companies have conducted or are currently conducting more than 4,700 clinical trials in South Carolina. In 2013 alone, the nearly 1,100 active clinical trials in the state generated an estimated economic impact of $540 million.

    “One of the most important things we want people to understand about medicine development is that clinical trials rely on patient participation,” said Nick McGee, Director of Public Affairs for PhRMA. “It’s incredibly important that patients are aware of ongoing trials and learn how they can help become part of finding a cure for the toughest chronic conditions and diseases we face today.”

    In the United States, there are more than 7,000 open clinical trials being sponsored by the biopharmaceutical industry, universities, individuals and organizations combined. In South Carolina, of the 572 open clinical trials involving the biopharmaceutical research industry, the University of South Carolina Medial School is collaborating on more than 143 clinical trials and the Medical University of South Carolina is collaborating on more than 142.

    “Many top research and medical universities call South Carolina home and are centers of innovation,” Bob Quinn, Executive Director of the South Carolina Research Authority, said. “Maintaining strong partnerships between our universities and life science companies allows us to foster developments right here in South Carolina that can then help save lives far beyond our state lines.”

    You can read the complete report, “Research in Your Backyard: Developing Cures, Creating Jobs, Pharmaceutical Clinical Trials in South Carolina,” here.

    ###

    About PhRMA
    The Pharmaceutical Research and Manufacturers of America (PhRMA) represents the country’s leading innovative biopharmaceutical research companies, which are devoted to discovering and developing medicines that enable patients to live longer, healthier, and more productive lives. Since 2000, PhRMA member companies have invested more than $600 billion in the search for new treatments and cures, including an estimated $71.4 billion in 2017 alone.

    About SC BIO
    SCBIO is South Carolina’s investor-driven public/private economic development organization focused on building, advancing, and growing the life sciences industry in the state.  With an $11.4 billion annual economic impact in the Palmetto State, with more than 400 firms and 15,000 professionals directly involved in the research, development and commercialization of innovative healthcare, medical device, industrial, environmental and agricultural biotech and products that make a difference across the Palmetto State and around the world.  Visit us at SCBIO.org.

  • Sam Patrick posted an article
    SCBIO 2019 Conference Draws Speakers, Takes Center Stage October 29-31 see more

    Conference registrations soar with sell-out expected; CEOs and top industry leaders from 30 states and countries expected in Greenville for strategic partnership development, industry insights

     

    SOUTH CAROLINA – September 11, 2019Johnson & Johnson Innovation Leader Michal Preminger will join more than 40 additional national speakers at SCBIO 2019 – the annual conference bringing top leaders and executives from life sciences organizations across the state and nation to South Carolina October 29-31.

    Following an October 29 welcome reception showcasing downtown Greenville, Ms. Preminger will address an expected sold-out conference at the Hyatt Regency with a keynote presentation entitled “Innovation for a Better Tomorrow” as the main program gets underway the morning of October 30.  Her presentation will be followed by a high-powered panel comprised of regional healthcare executives entitled “Optimizing the Future of Healthcare in SC and Beyond.” 

    Among other featured Conference programs are EY’sNextWave Wellness:  An Interactive View of the Future of Our Industry”, and an address by South Carolina Lieutenant Governor Pamela Evette entitled “South Carolina:  Just Right for Life Sciences.”  Clemson University President Jim Clements headlines Day 2 with an address entitled “The Power of Partnerships in Fueling Life Sciences”, while Medtronic global executive Christian Howell will address “Driving Value-Based Care Through Collaboration"

    Scores of top industry chief executives, leaders in government and higher education, biotechnology and pharma executives, clinicians and researchers, and industry supporters from across America have already registered to attend SCBIO 2019, with registration nearly doubling the record-setting pace of 2018.  Other committed speakers and panelists include IQVIA Institute of Health Data Science SVP Murray Aitken, Innova Therapeutics CEO and Founder Robert Ryan, ChartSpan CEO & Founder Jon-MIchial Carter, Firststring Research President Dr. Gautam Ghatnekar, Nephron Pharmaceuticals CEO Lou Kennedy, USC President (Ret.) Harris Pastides, PhRMA Senior Regional Director Thomas Hardaway and numerous others.  More than 20 programs will be featured over two days.

    Themed “Ignite The Future!”, the 2+ day conference draws attendees from across America for networking, innovation updates, opportunity discovery, partnership making and strategic discussion.  Committed attendees include officials across a broad spectrum of life sciences industries including medical devices, bio manufacturing, drug discovery, pharmaceuticals, diagnostics and testing, digital health and health IT, bio-ag and more.  Space is limited and advance registration is still available at https://www.scbio.org/cpages/register-now-for-scbio-2019.

    SCBIO is South Carolina’s investor-driven economic development organization exclusively focused on building, advancing, and growing the life sciences industry in the state.  The industry has a $12 billion economic impact in the Palmetto State, with more than 670 firms directly involved and over 43,000 professionals employed directly or indirectly in the research, development and commercialization of innovative healthcare, medical device, industrial, environmental and agricultural biotechnology products. 

    SCBIO 2019 kicks off Tuesday evening October 29 with a Grand Opening Reception for conference registrants, speakers and sponsors at Greenville’s ONE Center, presented by Prisma Health.  Wednesday will feature a complete day of sessions beginning at breakfast and continuing through an evening reception presented by the Greenville Area Development Corp., Greenwood Partnership Alliance and City of Greenville.  The conference will conclude Thursday at lunchtime. 

    “Life sciences is a major driver of South Carolina’s economy, and this conference’s growth is testament to the industry’s surging impact, reach and rapidly rising economic significance in our state and region,” noted SCBIO President and CEO Sam Konduros. “Already accounting for thousands of highly-skilled jobs in the Palmetto State, this sector has tremendous growth potential, and we’re excited to showcase the top companies, research universities and leaders from across our state and country at SCBIO 2019.” 

    Among leading biotech and med-tech industry brands participating in the conference are Nephron Pharmaceutical, BIO, Johnson & Johnson, AVX, PhRMA, Medpoint, AdvaMed, Poly-Med, VWR, Ritedose Corporation, Rhythmlink, SoftBox Systems, ZEUS, Patheon Thermo Fisher and more.  All of South Carolina’s research universities – MUSC, Clemson and the University of South Carolina – are represented, as are major healthcare systems, and economic development entities including the South Carolina Department of Commerce, SCRA, the Upstate SC Alliance, the Charleston Regional Development Alliance, Central Carolina Alliance, Economic Development Partnership and SiMT.

    As the official state affiliate of BIO -- the world's largest trade association representing biotechnology organizations – along with PhRMA and AdvaMed, SCBIO members include academic institutions, biotech companies, entrepreneurial organizations, service providers, thought leaders, economic development organizations and related groups whose members are leading the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology products that transform how we heal, fuel and feed the world.  For additional information on SCBIO, visit www.SCBIO.org.

  • Sam Patrick posted an article
    Life sciences in South Carolina is big business -- and getting bigger by the day. Read why... see more

    In this article published simultaneously in Charleston Business Magazine, Columbia Business Magazine and Greenville Business Magazine, SCBIO CEO Sam Konduros paints a picture of the diversity of the rapidly-growing life sciences industry, and why the future is exceedingly bright -- and getting brighter -- as the $11.4 billion industry soars to new heights across South Carolina.

     

    Life sciences in South Carolina spans a diverse spectrum—from major pharmaceutical companies to globally known medical device companies.

    It encompasses start-ups and early stage innovation companies and embraces prestigious research universities and acclaimed health care systems employing some of America’s finest minds. It includes research and medical labs, bioscience-related distribution, even Bio-Ag tied to the state’s historical agricultural segment. Click to read complete article...

  • Sam Patrick posted an article
    Life sciences is booming across South Carolina, experts report see more

    Compliments of Greenville Business Magazine

    The economic future of South Carolina is being profoundly impacted by a rising industry sector that has unexpectedly achieved the distinction of becoming the fastest-growing component of the Palmetto State’s knowledge economy.  

    Not automotive, not aerospace, but life sciences—a huge and multifaceted trillion-dollar-plus global industry that averages almost triple the R&D of all others, comprised of multiple segments, including drugs and pharmaceuticals, medical devices and equipment, digital health solutions, research-testing-medical labs, bio-science distribution, bio-ag and other life sciences support organizations.  

    The pharmaceutical segment in the U.S. alone employs approximately 3.5 million people, which exceeds the population of many states. Meanwhile, the medtech and digital health segments also continue to ramp-up dramatically, fueled by innovation and disruptive global trends ranging from the transformation of healthcare delivery to the enormous impact of artificial intelligence.

    According to SCBIO’s just released statewide S.C. Life Sciences Strategic Plan (Version 2.0 covering 2019-2021), an influx of new firms into the Palmetto State coupled with a comprehensive recount effort has surprisingly revealed that the number of life science companies with a presence in the Palmetto State has risen to more than 650—a figure which is over 200 more than were recognized in an initial economic impact study conducted approximately three years ago.  

    That foundational study funded by the state Department of Commerce and SCRA revealed an annual life sciences economic impact now conservatively approaching $12 billion, with more than 43,000 direct and indirect employees receiving wages almost double the state’s average, and an employment growth rate twice that of South Carolina as a whole. Perhaps even more compelling is the fact that life science entities are now present in 43 of 46 SC counties.  

    Established starring players in the Palmetto State’s rapidly evolving life sciences constellation such as Nephron Pharmaceuticals in West Columbia have grown from 400 employees to over 1,100 in the same time frame, with an accompanying capital investment close to $400 million dollars. Long-time South Carolina life science companies such as ZEUS Industrial Products in Orangeburg, Clemson University spin-out Poly-Med Inc., Sumter’s BD and Charleston’s Charles River Laboratories are achieving record employment numbers boosted by a growing global customer base.  

    Concurrently, new South Carolina biotech and medtech industry stars recently coming on line such as Thorne Research in Berkeley County and Arthrex in Anderson County have invested tens of millions of dollars in state-of-the-art facilities and are rapidly ramping up to projected employment levels in the hundreds.  

    Equally encouraging is the fact that scores of highly innovative early-stage life sciences companies like Charleston’s Firststring Research Inc.and Greenville’s Humimic Medical are becoming deeply rooted and committed to building their promising futures in South Carolina. This is a testament to the fact that a robust life sciences industry ecosystem is forming and maturing that not only supports larger scale advanced manufacturing operations, but can also foster and support innovative start-ups and early stage (pre-revenue) companies that must be uniquely bolstered in their early developmental years with a myriad of sophisticated resources, talent and funding sources in order to successfully enter the marketplace.  

    In years past, a multitude of promising, young South Carolina-born companies often left the state in order to obtain crucial funding and unique talent in more established bastions of life sciences such as Boston, the West Coast or even the nearby Research Triangle in North Carolina.  

    Gratefully, South Carolina is becoming a rising destination for both mature and early-stage life science companies that are fueled by all three of our major research universities and their extraordinary life sciences core competencies, renowned institutes such as the Greenwood Genetics Center, medical schools anchoring three major regions, the MUSC and Prisma Health science centers, and major healthcare providers.  

    They are also tapping into a growing bullpen of content experts in the Palmetto State ranging from experienced FDA navigators to reimbursement specialists to intellectual property attorneys and other highly specialized consultants 

    Based on the positive momentum of this burgeoning industry—which is virtually recession-proof and a huge diversification for South Carolina’s economy—hard-fought funding for SCBIO has reached a record high with new members joining forces with the organization on a weekly basis.  

    This crucial fuel is enabling unprecedented life sciences economic development strategies to be successfully mounted in the Palmetto State, including the active recruitment of a new generation of leading-edge life sciences companies into South Carolina from all over the world, in tandem and full alignment with vital state, regional and local partners—with recent economic development missions generating measurable results in Switzerland, Italy, Germany, Dubai (UAE), and across the U.S.  

    To achieve SCBIO’s bold vision of building the nation’s most industry-friendly and innovative life sciences ecosystem and business environment to fuel a knowledge economy in South Carolina, there is much work to be done—and it will be an endless journey. And in some respects, the Palmetto State is still somewhat fledgling as a global player in this complex and ever-changing industry.  However, South Carolina’s progress over the past decade has been nothing short of remarkable, and the opportunities are endless and unlimited. 

    Life sciences is now uniquely igniting and demonstrably contributing to a brilliant future for the state of South Carolina.  Please stay tuned—the best is yet to come. 

  • Sam Patrick posted an article
    SCBIO 2019 Conference Set to Ignite the Future of Life Sciences in Greenville SC see more

    Compliments of Greenville Business Magazine

    As the state’s only economic development organization and industry association exclusively focused on building, advancing and growing the life sciences industry, SCBIO continues to pack on muscle with an agile but growing executive team supported by public-private investors, a multi-disciplinary board of directors and a robust industry and innovation council loaded with industry experts.  

    Just as importantly, it is enabling SCBIO to identify and tackle challenging long-term issues that could impede future growth if not aggressively dealt with, ranging from impactful workforce development strategies to serving as an effective voice for the industry and its ongoing prosperity with respect to state and federal policy issues. 

    The newly minted strategic plan has accordingly outlined highly specific initiatives to deepen South Carolina’s life sciences talent pool, and that critical ongoing effort has been markedly propelled by bringing industry leaders and educators together for dynamic conversations in multiple venues across the state over the past year.  

    Highlighted talent initiatives range from the gathering and sharing of vital intelligence from life sciences industry executives to identifying best practices across the country and the state to emulate, to teaming up with Apprenticeship Carolina and statewide workforce partners, to reaching consensus with higher education leaders on the need for developing biotech and medtech curriculum tracks within the S.C. Technical College System, mirroring the success of similar strategies already employed by the better known automotive and aerospace industries.

    SCBIO is committed to a culture of collaboration, and to literally facilitating a multi-disciplinary and cross-functional “body contact sport” of sorts between industry, academia, clinicians, healthcare administrators, economic developers, core service providers, elected officials and business leaders that can achieve real results, and often doesn’t occur naturally. 

    Too often, the many diverse stakeholders required to successfully advance this industry are so busy in their unique and incredibly demanding spheres that it is difficult to consistently intersect and converge on issues and opportunities that can be accelerated and optimized when multiple experts are literally in the room.  As such, no strategic activity undertaken by the organization is more important than constantly convening and connecting the state’s life science industries with diverse but equally vital stakeholders and partners.

    And to that end, over 60 collaborative gatherings from board meetings to bootcamps to legislative receptions to corporate meet-ups are being facilitated by the organization in 2019 all across South Carolina, including the SCBIO Annual Conference—the crowning life sciences event of the year in the Palmetto State. This year’s conference is anticipated to be the largest ever and will take place at the Hyatt Regency in downtown Greenville October 29-31.  

    The agenda is loaded with global, national and state thought leaders and industry champions who will collaboratively focus on transformative issues, leading-edge technologies, disruptive healthcare initiatives, provocative policy issues and far-reaching trends that are both impacting and driving the domestic and international life sciences industry forward—with real and serious implications for South Carolina and its rising position within this global arena.  

    In addition to investors and stakeholders of SCBIO, interested non-members are encouraged to register and attend this dynamic, one-of-a-kind South Carolina gathering and high-impact learning and collaboration event. Visit www.SCBIO.org for details.

  • Sam Patrick posted an article
    Greenwood, SC is an emerging player in life sciences... see more

    As far as Sam Konduros, President and CEO of SCBIO, is concerned, the Palmetto State boasts a surprise player among the major hubs for cutting edge biotech study.

    “When I talk about the four major research institutions in the state of South Carolina, it’s our three research universities and Greenwood Genetic (Center), that’s how good that team is,” Konduros, CEO of SCBIO, told the Greenwood Partnership Alliance’s board this week. “People don’t know South Carolina as a life sciences story, they don’t know Greenwood, so we’re really surprising our own population with what we do have, and then we’re spending a lot of time trying to make sure that message is getting out around the world.”

    Read the full article here from the Greenwood Index Journal...

  • Sam Patrick posted an article
    SCBIO's Sam Konduros updates viewers on the advancements that the life sciences industry is making. see more

    SCBIO CEO Sam Konduros joins Carolina Business Review moderator Chris William for an interview airing recently across the Carolinas on the rapid growth and momentum that life sciences is experiencing across the Palmetto State, and some of the challenges in dealing with that growth. CBR is the most widely watched source for business and public policy issues across North and South Carolina.  Click here to enjoy the complete interview on YouTube.

  • Sam Patrick posted an article
    Greenwood County is one of South Carolina's hidden gems when it comes to life sciences see more

    This month, Greenville Business Magazine travels to see the incredible life sciences success stories emerging from nearby Greenwood, S.C.  

    As demand for health care grows and medical advances stretch from research to manufacturing, life sciences has become an inviting target industry for economic developers seeking to attract jobs and investment.  While some communities are learning as they go, Greenwood County has in one way or another made life sciences a priority for decades. It’s paying off in high-tech jobs and multi-million-dollar investments.  Read on for the complete story...

  • Sam Patrick posted an article
    SCBIO's expanded Board of Directors includes life sciences leaders from across South Carolina see more

    Organization’s Boards spans state, industry segments to provide unique blend of expertise for advancing South Carolina’s life sciences industry

     

    GREENVILLE, SC – February 8, 2019 – Less than two years after initiating a comprehensive relaunch of the state’s official life sciences organization, SCBIO has expanded its Board of Directors for its 501c6 operational entity and added a second 10-member Board for its 501c3 research and educational arm for 2019.  It does so having authored the state’s first-ever life sciences strategic growth plan, conducted an economic impact study validating the contributions of the $11.4 billion industry, tripled revenues and quadrupled membership – all since Spring 2017.

    And according to SCBIO President and CEO Sam Konduros, the best and most exciting days for the industry and organization are still ahead of it.

    “In a state perhaps best known for building BMWs and Boeing Dreamliners, there is a very strong life sciences story brewing as well, creating opportunities to diversify and accelerate growth of our state’s knowledge economy,” said Konduros recently.  He further cited rapid growth of such national and global brands including Nephron Pharmaceuticals, Arthrex, ZEUS, Abbott, Thorne and AVX as just a few examples of the state’s rapidly rising life sciences industry, which currently spans more than 400 companies in 44 counties and employs over 15,000 well-paid associates.

    Leading the policy- and strategy-making efforts of the 501c6 entity of the non-profit organization, the Board of Directors meets regularly to receive updates on SCBIO business objectives, domestic and global initiatives, and to help hone strategies and offer insight.  Nephron Pharmaceuticals Corporation CEO Lou Kennedy will serve as SCBIO’s 2019 Board Chair; Stephanie Yarbrough, Womble Bond Dickinson, LLP as Vice Chair; Michael Rusnak, Medical University of South Carolina Research Foundation as Treasurer; and Josh Ridley of ZEUS as Secretary. 

    Jeff Stover of Haynsworth Sinkler Boyd, PA will serve as Legal Officer; Heather Simmons Jones of the Greenwood Partnership Alliance as Annual Conference Officer; Bryan Davis of Prisma/Greenville Health System’s Office of Innovations as Healthcare/Innovation Officer; Adam Hoots of DPR Construction as Talent/Workforce Officer; and Sam Konduros, President and CEO of SCBIO. 

    Recently added members of the SCBIO Board of Directors are:

    Mike Briggs – President & CEO, Central SC Alliance

    Caroline Brown – Director of External Affairs, Medical University of South Carolina

    Thornton Kirby – President & CEO, South Carolina Hospital Association

    Adam Klonecke – Senior Site Director, Abbott

    Angie Leidinger – VP of External Affairs, Clemson University

    Tom McKenna – Chief Operating Officer, Thorne

    Robert Ryan – CEO & Founder, Innova Therapeutics

    Dave Shalaby – President, Poly-Med, Inc.

    Will Williams – President & CEO, Economic Development Partnership (Aiken)

    Cynthia Young – Dean, Clemson University College of Science

     

    Returning members of the SCBIO Board for 2019 are:

    Mandy Brawley – South Carolina Department of Commerce

    Matthew Couvillion – Wyche Law Firm

    John J. Darby – Johnson & Johnson Services

    Tressa Gardner – SE Institute of Manufacturing & Technology

    Mike Graney – Charleston Regional Development Alliance

    Chad Hardaway – University of South Carolina Office of Economic Engagement

    Will Harms – Blue Cross Blue Shield of SC

    Erica Jackson – K&L Gates

    Marc Metcalf – Upstate SC Alliance

    Kathy Phlegar – Phlegar & Associates

    Christine Dixon Thiesing – SCRA

    Courtney Warren – Marsh & McLennan Agency

     

    Comprising the smaller Board of SCBIO’s 501c3 research and educational arm are Kathryn Becker of Translational Science Solutions; Michael Bolick of Treis Blockchain; Matthew Couvillion of Wyche Law Firm; Shontavia Johnson of Clemson University; Steve Johnson of SCRA; Chris Przirembel, retired Clemson University executive; Shawn Regan of Rhythmlink; Craig Walker of Hitachi Healthcare Americas; Erica Jackson of K&L Gates; and SCBIO CEO Sam Konduros.

    SCBIO is South Carolina’s investor-driven public/private economic development organization exclusively focused on building, advancing, and growing the life sciences industry in the state.  The industry has an $11.4 billion annual economic impact in the Palmetto State, with more than 400 firms directly involved and 15,000 professionals employed in the research, development and commercialization of innovative healthcare, medical device, industrial, environmental and agricultural biotech and products.  The state-wide nonprofit has offices in Greenville, Columbia, and Charleston, and represents companies in advanced medicines, medical devices, diagnostics, IT, and healthcare outcome industries.

    SCBIO is the official state affiliate of BIO -- the world's largest trade association representing biotechnology organizations.  SCBIO members include academic institutions, biotech companies, med-tech companies, entrepreneurial organizations, service providers, thought leaders, economic development organizations and related groups whose members are leading the research and development of innovative healthcare, agricultural, industrial and environmental biotech and med-tech products that will make a difference across the Palmetto State, and around the world.

  • Sam Patrick posted an article
    Learn about South Carolina Life Sciences Feb. 20! see more

    Industry subject matter experts to cover what businesses need to know

    about life sciences, South Carolina’s fastest-growing industry segment

     

    GREENVILLE, SC – February 4, 2019 – SCBIO will host a full day program February 20, 2019 -- Life Sciences Boot Camp: Insights on SC’s Fastest-Growing Industry – to inform and update businesses and professionals from across the state on opportunities, trends and issues facing South Carolina’s fastest-growing industry segment.

    To be held at the University of South Carolina’s Alumni Center in Columbia, the program will run from 8:30 a.m. until 4:30 p.m. and will feature a light breakfast followed by presentations from over half a dozen noted life sciences industry leaders.  Confirmed presenters and their topics are:

    • Tushar Chikhliker, Partner, Nexsen Pruet, “Pharma Industry Challenges Opportunities & Legal Insights”
    • Kathy Phlegar, Principal, Phlegar & Associates, “Product Development and Commercialization: The Changing  Landscape of Bringing MedTech Products to Market”
    • Maureen Thomas, National Institute on Aging/National Institutes on Health, “Early Stage Funding:  Accessing SBIR-STTR Capital”
    • Erica Jackson, Partner, K&L Gates, “Navigating the FDA: An Overview of Medical Product Approvals and Enforcement Trends”
    • Dave McGlashan, Life Sciences Team Architect, DPR Construction, “Optimizing Capability & Efficiency in Your Life Sciences Facility”
    • Darralyn Alexander, President, Reimbursement Strategies – “How To Gain Reimbursement For My New Technology”
    • Sam Konduros, President & CEO, SCBIO – “South Carolina Life Sciences 2019:  A Look Forward”

    SCBIO Investor Organizations receive one registration at no charge, and additional attendees from Investor organizations pay only $50 for the entire day.  Individual Members of SCBIO pay only $50 for the entire program, while the general public and Non-Members can attend for just $125.  To register or for more details, visit the Events page at www.SCBIO.org/.

    An additional highlight of the day’s program on “Early Stage Funding:  Accessing SBIR-STTR Capital” will be when presenter Maureen Thomas is joined for discussion and open Q&A by Tyler Tatum and Ron Gorman of 3PhaseSC – South Carolina’s only free resource for SBIR/STTR grant consulting.  Attendees may also schedule 1-on-1 time for afternoon discussion with Ms. Thomas between 1:15 PM and 3:30 PM for more detailed conversation and guidance.

    SCBIO is South Carolina’s investor-driven public/private economic development organization exclusively focused on building, advancing, and growing the life sciences industry in the state.  The industry has an $11.4 billion annual economic impact in the Palmetto State, with more than 400 firms directly involved and 15,000 professionals employed in the research, development and commercialization of innovative healthcare, medical device, industrial, environmental and agricultural biotech and products.  The state-wide nonprofit has offices in Greenville, Columbia, and Charleston, and represents companies in the advanced medicines, medical devices, equipment, diagnostics, IT, and healthcare outcome industries.  Life sciences is recognized as the fastest-growing segment of South Carolina’s knowledge economy.

    SCBIO is also the official state affiliate of BIO -- the world's largest trade association representing biotechnology organizations.  SCBIO’s diverse membership is leading research and development of innovative healthcare, agricultural, industrial and environmental biotech and med-tech products that will make a difference across the Palmetto State, and around the world.

    For additional information on SCBIO, visit www.SCBIO.org.

  • Sam Patrick posted an article
    Top life sciences leaders from across the state have been named to the SCBIO Executive Committee see more

    Leadership team provides strategic blend of economic development, industry, higher education expertise

     

    GREENVILLE, SC – January 17, 2019 – SCBIO has announced its 2019 Executive Committee following formal confirmation at the life science organization’s December 2018 meeting in Columbia.  Nephron Pharmaceuticals Corporation CEO Lou Kennedy will serve a second term as SCBIO’s 2019 Board Chair.

    Ms. Kennedy joined Nephron Pharmaceuticals in 2001, and assumed the position of President and CEO in 2007. She has held a variety of marketing and operational roles during her career and has helped Nephron Pharmaceuticals grow by more than 300% and increased shipped product to one billion doses each of the last seven years.  Nephron constructed a state of the art manufacturing facility in West Columbia, South Carolina and, with her husband Bill, helped establish the Kennedy Pharmacy Innovation Center in conjunction with the USC School of Pharmacy.  The organization was honored as an inaugural winner of the South Carolina Life Sciences Pinnacle Award for Organizational Contribution to the industry in October, 2018.

    Joining Ms. Kennedy on the SCBIO Executive Committee will be Stephanie Yarbrough, Partner with Womble Bond Dickinson, LLP as Vice Chair; Michael Rusnak, Executive Director of the MUSC Foundation for Research Development as Treasurer; and Josh Ridley, Global Business Development Director of ZEUS as Secretary.  

    Additional members of the Executive Committee are Jeff Stover, Special Counsel with Haynsworth Sinkler Boyd, PA as Legal Officer; Heather Simmons Jones, CEO of the Greenwood Partnership Alliance as Annual Conference Officer; Bryan Davis, Operations Manager with Greenville Health System’s Office of Innovations as Healthcare/Innovation Officer; Adam Hoots, Life Sciences Market Leader for DPR Construction as Talent/Workforce Officer; and Sam Konduros, President and CEO of SCBIO. 

    Recognized for completing their terms as contributing members of the SCBIO Executive Committee were former Vice Chair Craig Walker, executive with Hitachi Healthcare Americas, and former Secretary Kathryn Becker, Principal with Translational Science Solutions LLC.

    SCBIO President and CEO Konduros praised the Executive Committee noting, “With the critically important efforts we are undertaking to advance pharmaceuticals, life sciences R&D, biotech, med-tech, and the health IT industries in South Carolina, we require strong, expert leadership from across the state, fully integrating our business, education and economic development sectors. These diverse leaders who represent the width and breadth of our state and industry will effectively champion our vision of building the business of life sciences in South Carolina for years to come.”

    SCBIO is South Carolina’s investor-driven public/private economic development organization exclusively focused on building, advancing, and growing the life sciences industry in the state.  The industry already has an $11.4 billion annual economic impact in the Palmetto State, with more than 400 firms directly involved and 15,000 professionals employed in the research, development and commercialization of innovative healthcare, medical device, industrial, environmental and agricultural biotech and products.  The state-wide nonprofit has offices in Greenville, Columbia, and Charleston, and represents companies in the advanced medicines, medical devices, equipment, diagnostics, IT, and healthcare outcome industries.

    The Executive Committee and Board of Directors is the policy- and strategy-making body of the organization, and meets regularly to receive updates on SCBIO business and objectives, as well as domestic and global initiatives. The Executive Committee serves roles specific to SCBIO operations, focus areas and strategies.

    SCBIO is the official state affiliate of BIO -- the world's largest trade association representing biotechnology organizations.  SCBIO members include academic institutions, biotech companies, med-tech companies, entrepreneurial organizations, service providers, thought leaders, economic development organizations and related groups whose members are leading the research and development of innovative healthcare, agricultural, industrial and environmental biotech and med-tech products that will make a difference across the Palmetto State, and around the world.

    For additional information on SCBIO, visit www.SCBIO.org

  • Sam Patrick posted an article
    SCBIO's Konduros named to GBM's 2018 Most Influential, Hall of Fame see more

    Greenville Business Magazine celebrates another year of honoring the region’s most influential people. The selection of our 50 individuals is a result of staff research and community nominations.

    We are also celebrating our fifth year of selecting entrants for our Hall of Fame. This year, we’re adding eight new members who have continued to make a lasting impact on the Upstate, including SCBIO President & CEO Sam Konduros.  Read on to enjoy the complete story.

  • Sam Patrick posted an article
    Building the business of life sciences in South Carolina has become the call to action of SCBIO... see more

    Building the business of life sciences in South Carolina has become the call to action and theme of the 2017 annual conference of the S.C. Biotechnology Organization (SCBIO).  The rapidly evolving statewide industry association is featured in this September 2017 issue of Charleston Business Magazine, and will be featured in October 2017 issues of Columbia Business and Greenville Business as well.  Click here for the full article.